The oligodendroglial lineage marker OLIG2 is universally expressed in diffuse gliomas - Wikidata - awgldk - TriplyDB

The oligodendroglial lineage marker OLIG2 is universally expressed in diffuse gliomas

The oligodendroglial lineage marker OLIG2 is universally expressed in diffuse gliomas

http://www.wikidata.org/entity/Q28267034

about

CD133 (Prominin) negative human neural stem cells are clonogenic and tripotent Development of NG2 neural progenitor cells requires Olig gene function Id4 and FABP7 are preferentially expressed in cells with astrocytic features in oligodendrogliomas and oligoastrocytomas Glioma Stem Cells and Their Microenvironments: Providers of Challenging Therapeutic Targets In vivo models of brain tumors: roles of genetically engineered mouse models in understanding tumor biology and use in preclinical studies Developmental origins of brain tumors Oligodendroglioma: pathology, molecular mechanisms and markers Brain tumor stem cells: Molecular characteristics and their impact on therapy MAPK pathway activation in pilocytic astrocytoma A high-content small molecule screen identifies sensitivity of glioblastoma stem cells to inhibition of polo-like kinase 1 Accelerating glioblastoma drug discovery: Convergence of patient-derived models, genome editing and phenotypic screening Olig2-regulated lineage-restricted pathway controls replication competence in neural stem cells and malignant glioma Phosphorylation state of Olig2 regulates proliferation of neural progenitors The central nervous system-restricted transcription factor Olig2 opposes p53 responses to genotoxic damage in neural progenitors and malignant glioma Purkinje cell maturation participates in the control of oligodendrocyte differentiation: role of sonic hedgehog and vitronectin Dysregulation of the Wnt pathway inhibits timely myelination and remyelination in the mammalian CNS Adult CST-null mice maintain an increased number of oligodendrocytes Coactivation of receptor tyrosine kinases affects the response of tumor cells to targeted therapies Culture conditions tailored to the cell of origin are critical for maintaining native properties and tumorigenicity of glioma cells.A Multicenter, Phase II, Randomized, Noncomparative Clinical Trial of Radiation and Temozolomide with or without Vandetanib in Newly Diagnosed Glioblastoma Patients.Cell of origin for malignant gliomas and its implication in therapeutic development Primary Meningeal Pleomorphic Xanthoastrocytoma With Anaplastic Features: A Report of 2 Cases, One With BRAF(V600E) Mutation and Clinical Response to the BRAF Inhibitor Dabrafenib A correlative optical microscopy and scanning electron microscopy approach to locating nanoparticles in brain tumors.Zebrafish neurofibromatosis type 1 genes have redundant functions in tumorigenesis and embryonic development.Identification of OLIG2 as the most specific glioblastoma stem cell marker starting from comparative analysis of data from similar DNA chip microarray platforms.OLIG2 is a useful immunohistochemical marker in differential diagnosis of clear cell primary CNS neoplasms.Glial progenitor-like phenotype in low-grade glioma and enhanced CD133-expression and neuronal lineage differentiation potential in high-grade glioma.CRX is a diagnostic marker of retinal and pineal lineage tumors A Sequentially Priming Phosphorylation Cascade Activates the Gliomagenic Transcription Factor Olig2.Multiple spatially related pharmacophores define small molecule inhibitors of OLIG2 in glioblastoma Effect of catalpol on remyelination through experimental autoimmune encephalomyelitis acting to promote Olig1 and Olig2 expressions in mice.Magnetic resonance imaging characteristics of glioblastoma multiforme: implications for understanding glioma ontogeny.Rosette-forming glioneuronal tumor: a pineal region case with IDH1 and IDH2 mutation analyses and literature review of 43 cases.MYCN amplification predicts poor outcome for patients with supratentorial primitive neuroectodermal tumors of the central nervous system An amino terminal phosphorylation motif regulates intranuclear compartmentalization of Olig2 in neural progenitor cells.Anaplastic astrocytoma mimicking progressive multifocal leucoencephalopathy: a case report and review of the overlapping syndromes Chronically increased ciliary neurotrophic factor and fibroblast growth factor-2 expression after spinal contusion in rats The top cited articles on glioma stem cells in Web of Science Potential therapeutic implications of cancer stem cells in glioblastoma Cerebellar gliomatosis in a toddler: case report of a challenging condition and review of the literature.

P2860

Q21562426-E7111F50-D45D-4CE1-8165-E5B9FCE34F77 Q24546061-98065A7E-0D44-4BE3-A567-9A32A4292487 Q24816392-4278D45E-08F3-47D5-A404-945615DA1FA6 Q26765758-3F6F77BE-8774-48FE-B8FA-D68A07A8BEBA Q26820289-7322DCAF-A368-45D6-9C81-489766C0F577 Q27000677-F14CF7A0-FA6D-4A72-B994-1ADB31E8D298 Q27002448-F5A87A8E-37A6-4A9C-91A2-3C5D65DB185A Q27003138-63081B38-A751-4487-8BB9-2B25119594B8 Q27006028-BD930B8F-1AAE-4B9B-B7F9-AED6970EC5DC Q27304385-0E7E096D-D14D-47EF-A7E5-771E0B4F83CD Q28080068-FBDB10C5-FB23-4C55-8567-E4A418947989 Q28287898-94D937BC-AB7B-4B4C-93DF-A7F7457ADB79 Q28306707-ABE3B1A9-C9F3-4B78-B9E3-76AE0EE365D3 Q28307211-DC3C3670-2AA5-49CB-BEC6-D714389CFFD4 Q28511964-BD696EFD-13CD-4DB5-AE45-A57222F10888 Q28589814-9392EC41-C326-4E96-AD76-9A0E8EF0B268 Q28828533-9D26566C-FCEE-44A7-AC97-0A525705485F Q29615606-F88BEAD1-F150-4C76-ACDA-2CF1AE05D4D5 Q30276928-2152BC18-9533-4300-87A0-FA1D5448EB2E Q30300114-D8D2F2BB-EE8D-47D3-8863-EA24BC415F64 Q30300877-22753AEC-FD23-4D51-8B3F-F27E99CFE13F Q30389253-4B0A6D1B-06A9-45EB-A68D-581182836ABD Q30394961-CF8BF3EF-EA6E-43BB-850D-2FFD63130777 Q30460793-62FA9C6B-1A91-4277-A1A7-A770D88A4983 Q30868592-CBFD42E0-ED41-470E-9182-9670410FCEF4 Q33270525-8F97F319-95F4-4B46-B9AA-3116C483960B Q33327359-27400A9B-B709-4479-A49C-64F8BA176E47 Q33516561-AB15354E-B907-4A38-9502-E5A793FB49E0 Q33571714-6E2CEB77-F3E0-4C53-A0B9-E011D1017601 Q33618337-D161066F-D970-4501-8E72-A4EC09A3A720 Q33630050-B8B02581-D918-4737-B4B0-A9BE9045CC97 Q33703639-FB8BE621-302F-4C57-AFC8-6F55799D6498 Q33703764-884159E8-819C-4C8B-9E86-925B867ED865 Q33753435-D81255BA-70E6-4986-AA28-69C2CD40A5A4 Q33770410-A100A3CD-1CD6-45E6-903D-1BD7AFA20149 Q33814485-62C27EFC-DE66-423D-A813-8EDE38A0C040 Q33919760-21672AC5-ECB3-43C7-BDAB-F99CC5EFB541 Q33937611-0813E961-196A-477B-8385-F811FB75D89A Q33965491-A127A0AB-FDA5-42AB-B26A-A6ACB1A1989F Q34028224-6C0427C1-4364-4F72-9ABA-31846F463324

P2860

The oligodendroglial lineage marker OLIG2 is universally expressed in diffuse gliomas

http://www.wikidata.org/entity/Q28267034

description

2004 nî lūn-bûn

@nan

2004 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

name

The oligodendroglial lineage marker OLIG2 is universally expressed in diffuse gliomas

@ast

The oligodendroglial lineage marker OLIG2 is universally expressed in diffuse gliomas

@en

The oligodendroglial lineage marker OLIG2 is universally expressed in diffuse gliomas

@nl

type

label

The oligodendroglial lineage marker OLIG2 is universally expressed in diffuse gliomas

@ast

The oligodendroglial lineage marker OLIG2 is universally expressed in diffuse gliomas

@en

The oligodendroglial lineage marker OLIG2 is universally expressed in diffuse gliomas

@nl

prefLabel

The oligodendroglial lineage marker OLIG2 is universally expressed in diffuse gliomas

@ast

The oligodendroglial lineage marker OLIG2 is universally expressed in diffuse gliomas

@en

The oligodendroglial lineage marker OLIG2 is universally expressed in diffuse gliomas

@nl

P1433

Q28267034-2E8002DE-30FF-4F2D-9ADD-3485046C5775

P1476

Q28267034-6A8E39B7-9AFE-4D5B-B3A7-F473E30E807D

P2093

Q28267034-0AD4A728-9115-4805-B74E-0BC25B8C833B

Q28267034-17D62FFF-53C4-4742-A60A-D260347D2AA0

Q28267034-4BC85243-5512-4AAB-BEE8-FFADDB6738AB

Q28267034-BF5635A8-3925-48B6-8379-5B62D144391F

Q28267034-C05AD83C-72E8-4A5B-8D3D-610A93DA225A

Q28267034-C5AC0070-4C77-4959-9F0C-09292FF78E2A

Q28267034-DA64658E-4FDF-4A63-9ED7-2E8D9B75E7D9

Q28267034-EB7678FE-F5D7-4481-B6BA-07E677C0CA73

Q28267034-F336E000-0172-4835-893A-878429E0F540

P2860

Q28267034-066AFB94-6A45-414F-BB42-374A121CE5EC

Q28267034-0B0E120C-397B-409A-925D-4DFB678F044B

Q28267034-162D524C-B7A6-4A77-BB54-0A749AA1F502

Q28267034-1DFA2311-74D2-4838-9615-0687F293796C

Q28267034-2145A8F3-0733-4200-8730-D0109A946FBE

Q28267034-21C0F8AB-BA1E-48D9-9D3C-4F19786FB842

Q28267034-26B28514-2B49-4074-BDEB-F9B4206B81E0

Q28267034-287B9ACE-FE66-439E-9963-4CB1943F40B8

Q28267034-390DF490-3209-4656-BAFA-6573EC9EC815

Q28267034-479A811A-5FD1-4038-A21D-B3FD681BB8DD

P304

Q28267034-50929D10-F93A-4715-A3D3-18705DD5F9B4

P31

Q28267034-E1BBCFED-3AE0-4EDA-8D6F-8D096C1C3CE6

P3181

Q28267034-0CD31FBE-E3AD-4187-AA10-0B71BCAB23D7

P356

Q28267034-053390D7-6C36-4E71-BB76-EE6D4F8A2D2E

P407

Q28267034-FF4BA124-75E5-4DE4-8105-E5CDEAC4A547

P433

Q28267034-3ADBF5DC-71CB-4C58-A9E2-7F88911DCAD4

P478

Q28267034-82E4F4C5-9BE8-4C8E-8FCF-722C4534252F

P577

Q28267034-ED01648D-677D-4A1C-9943-25B64D135CB8

P5875

Q28267034-58E1829B-D02D-470A-9CD6-D466D6B4EE23

P698

Q28267034-2F46D9FD-0331-4356-84C8-C0044024D02D

P921

Q28267034-0A9C9511-666B-45C3-8F44-85F38F9C3E54

P3181

P356

P1433

Journal of Neuropathology & Experimental Neurology

P1476

The oligodendroglial lineage marker OLIG2 is universally expressed in diffuse gliomas

@en

P2093

Alvin T Kho

http://www.w3.org/2001/XMLSchema#string

Catherine L Nutt

http://www.w3.org/2001/XMLSchema#string

Charles D Stiles

http://www.w3.org/2001/XMLSchema#string

David H Rowitch

http://www.w3.org/2001/XMLSchema#string

David N Louis

http://www.w3.org/2001/XMLSchema#string

Jennifer Weiss

http://www.w3.org/2001/XMLSchema#string

John A Alberta

http://www.w3.org/2001/XMLSchema#string

Keith L Ligon

http://www.w3.org/2001/XMLSchema#string

Mary R Kwaan

http://www.w3.org/2001/XMLSchema#string

P2860

Oligodendrocyte lineage genes (OLIG) as molecular markers for human glial brain tumors

Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications

Identification of neural stem cells in the adult vertebrate brain

Human cortical glial tumors contain neural stem-like cells expressing astroglial and neuronal markers in vitro

Identification of a novel family of oligodendrocyte lineage-specific basic helix-loop-helix transcription factors

Common developmental requirement for Olig function indicates a motor neuron/oligodendrocyte connection

Mammalian neural stem cells

Recent developments in the molecular characterization and treatment of oligodendroglial tumors

Dynamic expression of basic helix-loop-helix Olig family members: implication of Olig2 in neuron and oligodendrocyte differentiation and identification of a new member, Olig3.

A long, remarkable journey: tangential migration in the telencephalon.

P304

499-509

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

498440

http://www.w3.org/2001/XMLSchema#string

P356

10.1093/JNEN/63.5.499

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

63

http://www.w3.org/2001/XMLSchema#string

P577

2004-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8509703

http://www.w3.org/2001/XMLSchema#string

P698

15198128

http://www.w3.org/2001/XMLSchema#string

P921

oligodendrocyte